Schedule 13D ownership disclosure

Arcutis Biotherapeutics Inc

Common Stock, par value $0.0001 per share · CUSIP: 03969K108

Event date: 2025-08-18

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Frazier Life Sciences VIII, L.P.Reported CIK 0001655827

    Shares: 8,785,284.00 · Class: 7.3%

  • FHM LIFE SCIENCES VIII, L.P.Reported CIK 0001698755

    Shares: 8,785,284.00 · Class: 7.4%

  • FHM LIFE SCIENCES VIII, L.L.C.Reported CIK 0001698823

    Shares: 8,785,291.00 · Class: 7.4%

  • Frazier Life Sciences X, L.P.Reported CIK 0001790879

    Shares: 27,448.00 · Class: 0.0%

  • FHMLS X, L.P.Reported CIK 0001790880

    Shares: 27,448.00 · Class: 0.0%

  • FHMLS X, L.L.C.Reported CIK 0001790811

    Shares: 27,448.00 · Class: 0.0%

  • Frazier Life Sciences Public Fund, L.P.Reported CIK 0001863769

    Shares: 664,973.00 · Class: 0.6%

  • FHMLSP, L.P.Reported CIK 0001879466

    Shares: 664,973.00 · Class: 0.6%

  • FHMLSP, L.L.C.Reported CIK 0001879465

    Shares: 664,973.00 · Class: 0.6%

  • Frazier Life Sciences Public Overage Fund, L.P.Reported CIK 0001913804

    Shares: 196,170.00 · Class: 0.2%

  • FHMLSP Overage, L.P.Reported CIK 0001963247

    Shares: 196,170.00 · Class: 0.2%

  • FHMLSP Overage, L.L.C.Reported CIK 0001963248

    Shares: 196,170.00 · Class: 0.2%

  • Frazier Life Sciences XI, L.P.Reported CIK 0001911592

    Shares: 73,087.00 · Class: 0.1%

  • FHMLS XI, L.P.Reported CIK 0001911580

    Shares: 73,087.00 · Class: 0.1%

  • FHMLS XI, L.L.C.Reported CIK 0001911623

    Shares: 73,087.00 · Class: 0.1%

  • Frazier Life Sciences XII, L.P.Reported CIK 0002052255

    Shares: 127,549.00 · Class: 0.1%

  • FHMLS XII, L.P.Reported CIK 0002052246

    Shares: 127,549.00 · Class: 0.1%

  • FHMLS XII, L.L.C.Reported CIK 0002052177

    Shares: 127,549.00 · Class: 0.1%

  • James N. TopperReported CIK 0001341382

    Shares: 8,843,386.00 · Class: 7.4%

  • Patrick J. HeronReported CIK 0001365617

    Shares: 8,943,712.00 · Class: 7.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-022498
Form type
SCHEDULE 13D/A
Filer
Arcutis Biotherapeutics, Inc.
CIK
CIK 1787306
Filed
Aug 20, 2025
Reporting period
Aug 18, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub